Barely Significant
← all excerpts

Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease.

Front Pharmacol · 2021 · PMC8650159 · PMID 34887752

1
hedged sentence
closest p
boldest claim

The sentences

a clear trendno p-value reported
Functional enrichment analysis in sputum cells highlighted a clear trend toward decreased inflammatory conditions with a significant modulation of key COPD pathways involved in cytokine activity, pathogen-associated-pattern-recognition activity, oxidative stress and vitamin D with associated inhibition of downstream inflammatory effectors ( Govoni et al., 2020 ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.